Related references
Note: Only part of the references are listed.The Prospective Ameliorative Role of Zinc Oxide Nanoparticles in STZ-Induced Diabetic Nephropathy in Rats: Mechanistic Targeting of Autophagy and Regulating Nrf2/TXNIP/NLRP3 Inflammasome Signaling
Sarah Ragab Abd El-Khalik et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2022)
The combination of ursolic acid and empagliflozin relieves diabetic nephropathy by reducing inflammation, oxidative stress and renal fibrosis
Xiaohan Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Comparative risk of new-onset hyperkalemia for antihypertensive drugs in patients with diabetic nephropathy: A Bayesian network meta-analysis
Simin Zhu et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats
Jiawei Chen et al.
LIFE SCIENCES (2021)
Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development
Vicki Thallas-Bonke et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Antidiabetic nephropathy effects of synthesized gold nanoparticles through mitigation of oxidative stress
Yanfang Yu et al.
ARABIAN JOURNAL OF CHEMISTRY (2021)
Chronic kidney disease prevalence and cardiovascular risk in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (Spain). An observational study
Juan Ignacio Calvo-Hueros et al.
PRIMARY CARE DIABETES (2021)
Nephrotic range proteinuria associated with focal segmental glomerulosclerosis reversed with pioglitazone therapy in a patient with Dunnigan type lipodystrophy
Anjul Sharma et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Changes in serum uric acid levels as a predictor of future decline in renal function in older adults with type 2 diabetes
Yusuke Shibata et al.
MEDICINE (2021)
Nanomedicine in the treatment of diabetic nephropathy
Nimeet Desai et al.
FUTURE MEDICINAL CHEMISTRY (2021)
Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
Tingting Li et al.
FRONTIERS IN PHYSIOLOGY (2021)
Use of renin-angiotensin-aldosterone system blockade in controversial chronic kidney disease populations
Ana Maria Garcia-Prieto et al.
MEDICINA CLINICA (2021)
Chronic Kidney Disease: Strategies to Retard Progression
Ming-Tso Yan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Potential Role of Protein Kinase C in the Pathophysiology of Diabetes-Associated Atherosclerosis
Chih-Feng Lien et al.
FRONTIERS IN PHARMACOLOGY (2021)
Nanotechnology, Nanomedicine, and the Kidney
Peter Hauser et al.
APPLIED SCIENCES-BASEL (2021)
Protein/Gold Nanoparticle-Based Sensors for Monitoring the Progression of Adriamycin Nephropathy
Xuefei Bai et al.
ACS APPLIED NANO MATERIALS (2021)
Design and optimization strategies for the development of new drugs that treat chronic kidney disease
Adrian M. Ramos et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Study of the target effect of mannose modified liposomes on diabetic rat kidney based on GLUT
Shigui Yang et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
Celia Faustino et al.
PHARMACEUTICS (2020)
Recent advances in nanotechnology-based drug delivery systems for the kidney
Fatemeh Oroojalian et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Improving Molecular Therapy in the Kidney
Jeffrey D. Rubin et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
Lili Zhang et al.
JOURNAL OF DIABETES RESEARCH (2020)
Lysosomal dysfunction-induced autophagic stress in diabetic kidney disease
Hui Juan Zheng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Advances in kidney-targeted drug delivery systems
Zhong Chen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
Junko Yabuuchi et al.
SCIENTIFIC REPORTS (2020)
Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
Jie Xu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Personalized treatment for coronary artery disease patients: a machine learning approach
Dimitris Bertsimas et al.
HEALTH CARE MANAGEMENT SCIENCE (2020)
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic
Erkan Cure et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Detailed Review of Chronic Kidney Disease
Yesubabu Kakitapalli et al.
KIDNEY DISEASES (2020)
Design and evaluation of glomerulus mesangium-targeted PEG-PLGA nanoparticles loaded with dexamethasone acetate
Sha Li et al.
ACTA PHARMACOLOGICA SINICA (2019)
Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules
Chun-Ping Liu et al.
MEDICINAL RESEARCH REVIEWS (2019)
Synthesis and evaluation of injectable thermosensitive penta-block copolymer hydrogel (PNIPAAm-PCL-PEG-PCL-PNIPAAm) and star-shaped poly(CLCOLA)-b-PEG for wound healing applications
Fatemeh Oroojalian et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
TGF-β and Diabetic Nephropathy: Lessons Learned over the Past 20 Years
Leslie S. Gewin
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)
Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury
Jean-Christophe Wyss et al.
FRONTIERS IN PHARMACOLOGY (2019)
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Lifestyle Management: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Kidney-targeted rhein-loaded liponanoparticles for diabetic nephropathy therapy via size control and enhancement of renal cellular uptake
Guowei Wang et al.
THERANOSTICS (2019)
Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia-reperfusion injury in the rat
Carla M. A. van Alem et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment
Maryam Afsharzadeh et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Targeting renal fibrosis: Mechanisms and drug delivery systems
Madalina V. Nastase et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage
Jing-Bo Hu et al.
CARBOHYDRATE POLYMERS (2018)
Renal fibrosis: Primacy of the proximal tubule
Leslie S. Gewin
MATRIX BIOLOGY (2018)
Glomerular mesangial cell and podocyte injuries in diabetic nephropathy
Chun-Wu Tung et al.
NEPHROLOGY (2018)
Deep Eutectic Solvent-Mediated FA-g-β-Alanine-co-PCL Drug Carrier for Sustainable and Site-Specific Drug Delivery
Periyakaruppan Pradeepkumar et al.
ACS APPLIED BIO MATERIALS (2018)
Pathology identifies glomerular treatment targets in diabetic nephropathy
Charles E. Alpers et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2018)
Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal Fc receptor in glomerular podocytes
Lin Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Megalin-targeted enhanced transfection efficiency in cultured human HK-2 renal tubular proximal cells using aminoglycoside-carboxyalkyl-polyethylenimine -containing nanoplexes
Fatemeh Oroojalian et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes
Ray El Boustany et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
A kidney-selective biopolymer for targeted drug delivery
Gene L. Bidwell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial
Per-Henrik Groop et al.
DIABETES OBESITY & METABOLISM (2017)
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Ian H. de Boer et al.
DIABETES CARE (2017)
Polymer Nanoparticle Engineering for Podocyte Repair: From in Vitro Models to New Nanotherapeutics in Kidney Diseases
Claudio Colombo et al.
ACS OMEGA (2017)
Podocytes: the Weakest Link in Diabetic Kidney Disease?
Jamie S. Lin et al.
CURRENT DIABETES REPORTS (2016)
Nanomedicines for renal disease: current status and future applications
Nazila Kamaly et al.
NATURE REVIEWS NEPHROLOGY (2016)
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
Sripal Bangalore et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
Sripal Bangalore et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy
Yanjuan Hou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives
Meng Lv et al.
DRUG DISCOVERY TODAY (2015)
Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus
Daniela Dunkler et al.
KIDNEY INTERNATIONAL (2015)
Mesoscale Nanoparticles Selectively Target the Renal Proximal Tubule Epithelium
Ryan M. Williams et al.
NANO LETTERS (2015)
siRNA Delivery to the Glomerular Mesangium Using Polycationic Cyclodextrin Nanoparticles Containing siRNA
Jonathan E. Zuckerman et al.
NUCLEIC ACID THERAPEUTICS (2015)
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Katherine R. Tuttle et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy
Goru Santosh Kumar et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Megalin-Mediated Specific Uptake of Chitosan/siRNA Nanoparticles in Mouse Kidney Proximal Tubule Epithelial Cells Enables AQP1 Gene Silencing
Shan Gao et al.
THERANOSTICS (2014)
Kidney-targeted drug delivery systems
Peng Zhou et al.
ACTA PHARMACEUTICA SINICA B (2014)
Targeting Therapeutics to the Glomerulus With Nanoparticles
Jonathan E. Zuckerman et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2013)
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
Harikrishna Makani et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Endothelial Glycocalyx: Permeability Barrier and Mechanosensor
F. E. Curry et al.
ANNALS OF BIOMEDICAL ENGINEERING (2012)
Cell Biology and Pathology of Podocytes
Anna Greka et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 74 (2012)
Prednisolone succinate-glucosamine conjugate: Synthesis, characterization and in vitro cellular uptake by kidney cell lines
Yan Lin et al.
CHINESE CHEMICAL LETTERS (2012)
Inflammation imaging by silica nanoparticles with antibodies orientedly immobilized
Tomoaki Shirai et al.
JOURNAL OF DRUG TARGETING (2012)
Kidney-Specific Peptide-Conjugated Poly(ester amine) for the Treatment of Kidney Fibrosis
You-Kyoung Kim et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2012)
The podocyte as a target for therapies-new and old
Peter W. Mathieson
NATURE REVIEWS NEPHROLOGY (2012)
The pathogenic role of the renal proximal tubular cell in diabetic nephropathy
Sydney C. W. Tang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Vasopressin V2R-Targeting Peptide Carrier Mediates siRNA Delivery into Collecting Duct Cells
Hyun Jun Jung et al.
PLOS ONE (2012)
Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane
Jonathan E. Zuckerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Enhanced accumulation of low-molecular-weight chitosan in kidneys: a study on the influence of N-acetylation of chitosan on the renal targeting
Zhi-xiang Yuan et al.
JOURNAL OF DRUG TARGETING (2011)
Glomerular basement membrane composition and the filtration barrier
Jeffrey H. Miner
PEDIATRIC NEPHROLOGY (2011)
Pathophysiology of the Diabetic Kidney
Volker Vallon et al.
COMPREHENSIVE PHYSIOLOGY (2011)
Mesangial pathology in glomerular disease: targets for therapeutic intervention
Yogesh M. Scindia et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Specific Renal Uptake of Randomly 50% N-Acetylated Low Molecular Weight Chitosan
Zhi-xiang Yuan et al.
MOLECULAR PHARMACEUTICS (2009)
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt C. Fellstroem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier
Simon C. Satchell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Magnetic resonance imaging of major histocompatibility class II expression in the renal medulla using immunotargeted superparamagnetic iron oxide nanoparticles
Kristi L. Hultman et al.
ACS NANO (2008)
MRI of the basement membrane using charged nanoparticles as contrast agents
Kevin M. Bennett et al.
MAGNETIC RESONANCE IN MEDICINE (2008)
Antihypertensive agents for preventing diabetic kidney disease
G. F. M. Strippoli et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Poly(vinylpyrrolidone-co-dimethyl maleic acid) as a novel renal targeting carrier
Y Yamamoto et al.
JOURNAL OF CONTROLLED RELEASE (2004)
The targeting of anionized polyvinylpyrrolidone to the renal system
H Kodaira et al.
BIOMATERIALS (2004)
Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells
JH Robben et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Arginine-rich molecular transporters for drug delivery: Role of backbone spacing in cellular uptake
JB Rothbard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
